<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101731730</journal-id>
<journal-id journal-id-type="pubmed-jr-id">47983</journal-id>
<journal-id journal-id-type="nlm-ta">Biochim Biophys Acta Mol Basis Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Biochim Biophys Acta Mol Basis Dis</journal-id>
<journal-title-group>
<journal-title>Biochimica et biophysica acta. Molecular basis of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0925-4439</issn>
<issn pub-type="epub">1879-260X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29317335</article-id>
<article-id pub-id-type="pmc">6501568</article-id>
<article-id pub-id-type="doi">10.1016/j.bbadis.2018.01.007</article-id>
<article-id pub-id-type="manuscript">NIHMS938150</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Yao</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Jiun-Sheng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Fulan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fowler</surname>
<given-names>Jerry</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scheet</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Hua</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huff</surname>
<given-names>Chad D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA</aff>
<aff id="A2"><label>2</label>The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston,
Texas, USA</aff>
<aff id="A3"><label>3</label>Department of Epidemiology, Public Health College, Harbin Medical University, Harbin, Heilongjiang 150081,
China</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author contribution</p>
<p id="P2">CH conceived of the study; YY, HH, JC, FH, and CH conducted association analyses; JF, PS, YY, and CH conducted copy
number alteration analyses; CH, YY, PS, and HZ interpreted results; YY prepared figures; and YY and CH prepared and wrote the
manuscript. All authors approved submission of the manuscript in its present form.</p>
</fn>
<corresp id="CR1">Correspondence should be addressed to C.H. (<email>chad@hufflab.org</email>).</corresp>
<fn fn-type="COI-statement" id="FN4">
<p id="P32">Competing interests</p>
<p id="P33">The authors declare that they have no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>1864</volume>
<issue>6 Pt B</issue>
<fpage>2247</fpage>
<lpage>2254</lpage>
<!--elocation-id from pubmed: 10.1016/j.bbadis.2018.01.007-->
<abstract id="ABS1">
<p id="P3">While a number of genes have been implicated in melanoma susceptibility, the role of protein-coding variation in melanoma
development and progression remains underexplored. To better characterize the role of germline coding variation in melanoma, we
conducted a whole-exome case-control and somatic-germline interaction study involving 322 skin cutaneous melanoma cases from The
Cancer Genome Atlas and 3,607 controls of European ancestry. We controlled for cross-platform technological stratification using
XPAT and conducted gene-based association tests using VAAST 2. Four established melanoma susceptibility genes achieved nominal
statistical significance, <italic>MC1R</italic> (p = 0.0014), <italic>MITF</italic> (p = 0.0165) <italic>BRCA2</italic> (p =
0.0206), and <italic>MTAP</italic> (p = 0.0393). We also observed a suggestive association for <italic>FANCA</italic> (p=0.002), a
gene previously implicated in melanoma survival. The association signal for <italic>BRCA2</italic> was driven primarily by likely
gene disrupting (LGD) variants, with an Odds Ratio (OR) of 5.62 (95% Confidence Interval (CI) 1.03 â€“ 30.1). In contrast,
the association signals for <italic>MC1R</italic> and <italic>MITF</italic> were driven primarily by predicted pathogenic non-LGD
coding variants, with estimated ORs of 1.4 to 3.0 for <italic>MC1R</italic> and 4.1 for <italic>MITF</italic>.
<italic>MTAP</italic> exhibited an excess of both LGD and predicted damaging non-LGD variants among cases, with ORs of 5.62
and 3.72, respectively, although neither category was significant. For individuals with known or predicted damaging variants, age
of disease onset was significantly lower for two of the four genes, <italic>MC1R</italic> (p=0.005) and <italic>MTAP</italic>
(p=0.035). In an analysis of germline carrier status and overlapping copy number alterations, we observed no evidence to support a
two-hit model of carcinogenesis in any of the four genes. Although <italic>MC1R</italic> carriers were represented proportionally
among the four molecular tumor subtypes, these individuals accounted for 69% of ultraviolet (UV) radiation mutational signatures
among triple-wild type tumors (p = 0.040), highlighting the increased sensitivity to UV exposure among individuals with
loss-of-function variants in <italic>MC1R</italic>.</p>
</abstract>
<kwd-group>
<kwd>case-control study</kwd>
<kwd>whole exome association analysis</kwd>
<kwd>skin cutaneous melanoma</kwd>
<kwd>cancer susceptibility gene</kwd>
<kwd>somatic-germline interaction</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>